Answers are grounded in this paper and cite their sources.
Meta-analysis reveals comparable mortality but reduced sepsis and transfusions with minimally invasive surgery in mitral valve endocarditis, suggesting it is a safe alternative to sternotomy.
Objective We aimed to compare early and late postoperative clinical outcomes between minimally invasive surgery (MIS) and full sternotomy (FS) in patients with mitral valve (MV) infective endocarditis (IE). Methods This meta-analysis was conducted in compliance with the PRISMA guidelines. PubMed, Scopus, and Web of Science databases were searched for any randomized control trials or cohort studies that compared MIS versus FS in surgery for mitral valve infective endocarditis. Results Four cohort studies with 466 patients (137 in MIS group and 329 in FS group), were included in our study. Pooled analysis showed no significant difference between MIS and FS in terms of in-hospital/30-day mortality (RR = 0.71, 95% CI [0.31-1.60], p -value = 0.40), stroke (RR = 0.63, 95% CI [0.16-2.46], p -value = 0.50), atrial fibrillation (RR = 0.89, 95% CI [0.57-1.40], p -value = 0.62), acute kidney injury/renal failure (RR = 0.51, 95% CI [0.22-1.16], p -value = 0.11), multi-organ failure (RR = 0.94, 95% CI [0.33-2.70], p -value = 0.90), and readmission rates (RR = 0.75, 95% CI [0.39-1.45], p -value = 0.39). However, our study showed a statistically significant association between MIS and lower risk of postoperative sepsis (RR = 0.17, 95% CI [0.03-0.84], p -value = 0.03), fewer blood transfusions (RR = 0.63, 95% CI [0.48-0.84], p -value = 0.001), and shorter length of ICU stay (RR = −1.57, 95% CI [−2.16, −0.97], p -value <0.00001) compared to FS. The pooled effect estimate showed no significant difference between both groups in terms of need for reoperation, permanent pacemaker implantation, survival up to 2.5 years, and IE recurrence up to 3.5 years. Conclusions Our findings suggest that MIS may be a safe and cost-effective alternative for FS in patients undergoing surgery for mitral valve infective endocarditis. Surgical approach should be tailored to the patient’s clinical risk profile, the extent of endocarditis, and the team’s experience, to ensure optimal clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Motawea et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: